Related Experiment Videos
[Analysis of the dopamine D2 receptor gene]
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
|June 1, 1994
Summary
Researchers explored sequence variants in the human dopamine D2 receptor (DRD2) gene. They investigated a specific missense variant associated with schizophrenia using various PCR-based methods for genotyping.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Context:
- The human dopamine D2 receptor (DRD2) gene plays a crucial role in neurological functions.
- Sequence variants in the DRD2 gene are implicated in various neuropsychiatric disorders.
- Schizophrenia is a complex disorder with potential genetic underpinnings.
Purpose:
- To describe methods for detecting sequence variants in the human DRD2 gene, including Southern blot hybridization, PCR-direct sequencing, and PCR-Single-Strand Conformation Polymorphism (SSCP).
- To investigate the association of a specific DRD2 gene missense variant (Ser311-->Cys) with schizophrenia.
- To genotype control and schizophrenic populations using PCR-dot blot hybridization, PCR amplification of specific alleles, and PCR-Restriction Fragment Length Polymorphism (RFLP).
Summary:
- Several molecular methods were detailed for identifying variations within the DRD2 gene.
- A missense variant (Ser311-->Cys) in the DRD2 gene was detected using PCR-direct sequencing in individuals with schizophrenia.
- Genotyping of controls and schizophrenics for this variant was performed using PCR-dot blot hybridization, allele-specific PCR, and PCR-RFLP.
Impact:
- This study provides a methodological framework for DRD2 gene variant detection.
- The findings contribute to understanding the genetic factors associated with schizophrenia.
- The employed genotyping techniques offer efficient means for large-scale genetic association studies in psychiatric genetics.